Endometriosis in a Postmenopausal Woman on Hormonal Replacement Therapy

Jeon DS, Dong-Su Jeon, Tae‐Hee Kim, Kim TH, Tae-Hee Kim, Lee HH, Hae-Hyeog Lee, Hae‐Hyeog Lee, Dong Won Byun, Byun DW
Journal of menopausal medicine · 2013 · vol. 19(3) , pp. 151 · doi:10.6118/jmm.2013.19.3.151 · PMID:25371883 · PMC4217556 · W2134992413
article OA: gold CC0 ⤵ 14 in-corpus citations
📄 Open PDF Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

This report details a rare case of endometriosis appearing in a postmenopausal woman after initiating hormone replacement therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text ⓘ

This paper reports a case and literature review of postmenopausal endometriosis in a 51-year-old woman who had no prior history of endometriosis, developed abdominal pain, and was taking hormone replacement therapy (HRT) for 5 years after menopause. Using pelvic ultrasonography and CT, clinicians provisionally diagnosed a left ovarian endometrioma; CA125 was markedly elevated but later decreased, and laparoscopic left salpingo-oophorectomy revealed a cyst with chocolate-colored fluid, with pathology confirming an ovarian endometriotic cyst. The paper notes that postmenopausal endometriosis is rare and discusses proposed estrogen-dependent mechanisms, including potential effects of HRT (and higher endogenous estrogen in obese women), and it highlights that malignancy transformation has been reported (0.7–1.0%). The paper’s main limitation is that it is a single case report with a narrative review rather than new experimental evidence. This paper is centrally about endometriosis — specifically, endometriosis presenting after menopause in a woman receiving HRT.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a benign disease and an estrogen-dependent disease. Postmenopausal endometriosis is rare, because the absence of estrogenic hormone production. We report a case of endometriosis presenting in a postmenopausal woman with no history of endometriosis before hormone replacement therapy.
Full text 3,400 characters · extracted from pmc-nxml · 3 sections · click to expand

Case

A 51-year-old woman, weighing 53 kg and 150 cm tall, presented with abdominal pain. The multiparous woman had undergone menopause at 45 years of age. Subsequently, she took HRT for 5 years and was in good general health until an ovarian tumor was detected on ultrasonography. She had no family or personal history of endometriosis. A pelvic ultrasound revealed a 2.5 × 2.5 cm left ovarian homogeneous cystic mass ( Fig. 1 ). Computed tomography (CT) revealed a high-density 3.8 cm left adnexal cystic lesion ( Fig. 2 ). Her cancer antigen (CA) 125 level was 551.9 U/mL (normal < 35.0 U/mL). The other CA serum markers (alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and beta human chorionic gonadotropin) were within their normal ranges. The data and image suggested a provisional diagnosis of left ovarian endometrioma. She was followed in our outpatient department for 6 months and the cystic tumor grew larger. However, the CA 125 level decreased to 62.1 U/mL. She decided to undergo a laparoscopic left salpingo-oophorectomy, which revealed a cystic left adnexal mass. Chocolate-colored fluid was observed in the ruptured ovarian cyst. Pathological examination of the excised tumor confirmed that it was an ovarian endometriotic cyst.

Intro

Endometriosis is a benign disease involving ectopic endometrial glands or stroma that abnormally adhere to and spread to tissue outside of the uterus. 1 Endometriosis is an estrogen-dependent disease that usually occurs in women of reproductive age. Postmenopausal endometriosis is rare, because the absence of estrogenic hormone production should prevent estrogen-dependent endometriosis. 2 The incidence of endometriosis in postmenopausal women is low and estimated to be 2-4%. 3 It has been suggested that hormone replacement therapy (HRT) can reactivate residual endometriosis or even produce new implants in climacteric women with a history of endometriosis. 4 We report a case of endometriosis presenting in a postmenopausal woman with no history of endometriosis before menopause and review the literature.

Discussion

Postmenopausal endometriosis is a rare disease, which was first reported in 1950. Endometriosis was found in 22% of 903 postmenopausal women. 5 Regardless of the origins of the lesions themselves, endometriosis is widely considered to be an estrogen-dependent disorder. 6 In postmenopausal women, estrogen is produced mainly in the skin and adipose tissue. 6 Obese postmenopausal women produced much more endogenous estrogen than non-obese women, which may result in elevated serum estradiol levels. 6 The use of HRT can cause an increased, although undefined, risk of recurrent endometriosis, especially in obese patients. 7 HRT might cause endometriosis-associated symptoms in the postmenopausal population. 7 Our patient had no history of gynecologic problems and developed endometriosis after menopause while on HRT. Although postmenopausal endometriosis is usually benign, it is important to be aware of this condition, as it is increasingly recognized to have malignant potential. 8 The reported frequency of malignancy transformation is 0.7-1.0%. 9 After removing an endometriotic cyst, we should follow the patient because of possible malignant transformation. We experienced a case of postmenopausal endometriosis during HRT. Endocrinologists prescribing hormone replacement therapy should be aware of this condition.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (9)

Cited by (14)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:10.358439+00:00
License: CC0 · commercial use OK